Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
TriCo Bancshares
TCBK
$1.83B
| $1.44M | ﹤0.01% |
47,379
+8,815
| +23% | +$251K |
|
2402
Independence Realty Trust
IRT
$4.07B
| $1.44M | ﹤0.01% |
125,621
+2,560
| +2% | +$25.5K |
|
|
LMNX
2403
DELISTED
Luminex Corp
LMNX
| $1.44M | ﹤0.01% |
44,239
+9,475
| +27% | +$300K |
|
2404
PUT
ICU Medical
ICUI
$4.61B
| $1.44M | ﹤0.01% |
7,800
-12,200
| -61% | -$2.42M |
|
2405
John Wiley & Sons Class A
WLY
$2.66B
| $1.43M | ﹤0.01% |
36,774
+29,215
| +386% | +$1.12M |
|
2406
Fulton Financial
FULT
$4.64B
| $1.43M | ﹤0.01% |
135,981
+22,104
| +19% | +$240K |
|
|
RPT
2407
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.43M | ﹤0.01% |
205,137
+4,902
| +2% | +$31.2K |
|
2408
Texas Pacific Land
TPL
$23.5B
| $1.43M | ﹤0.01% |
+21,600
| New | +$1.33M |
|
|
IMGN
2409
DELISTED
Immunogen Inc
IMGN
| $1.43M | ﹤0.01% |
309,960
+173,705
| +127% | +$739K |
|
2410
WEX
WEX
$6.31B
| $1.42M | ﹤0.01% |
8,618
-19,359
| -69% | -$2.66M |
|
2411
Walker & Dunlop
WD
$1.53B
| $1.42M | ﹤0.01% |
27,925
+2,900
| +12% | +$119K |
|
2412
CALL
Thor Industries
THO
$4.14B
| $1.42M | ﹤0.01% |
13,300
-24,200
| -65% | -$1.89M |
|
|
FMBI
2413
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.42M | ﹤0.01% |
106,132
+17,903
| +20% | +$238K |
|
2414
PUT
Cintas
CTAS
$81.3B
| $1.41M | ﹤0.01% |
21,200
-19,200
| -48% | -$1.11M |
|
2415
Associated Banc-Corp
ASB
$5.91B
| $1.41M | ﹤0.01% |
103,111
-12,421
| -11% | -$169K |
|
2416
PUT
Centene
CNC
$32.5B
| $1.41M | ﹤0.01% |
22,112
-117,000
| -84% | -$7.62M |
|
2417
ProPetro Holding
PUMP
$1.35B
| $1.4M | ﹤0.01% |
272,804
+4,572
| +2% | +$21.1K |
|
2418
Macerich
MAC
$6.92B
| $1.4M | ﹤0.01% |
156,188
-8,604
| -5% | -$66.7K |
|
|
K
2419
CALL
DELISTED
Kellanova
K
| $1.39M | ﹤0.01% |
22,472
-11,608
| -34% | -$703K |
|
|
XEC
2420
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $1.39M | ﹤0.01% |
50,700
+36,600
| +260% | +$908K |
|
|
PPL
2421
CALL
PPL Corp
PPL
$26.7B
| $1.39M | ﹤0.01% |
53,900
-55,900
| -51% | -$1.45M |
|
2422
Kura Oncology
KURA
$850M
| $1.39M | ﹤0.01% |
85,278
+49,130
| +136% | +$709K |
|
|
BEAT
2423
DELISTED
BioTelemetry, Inc.
BEAT
| $1.39M | ﹤0.01% |
30,743
-42,280
| -58% | -$1.89M |
|
2424
Methode Electronics
MEI
$592M
| $1.39M | ﹤0.01% |
44,382
+1,474
| +3% | +$44.2K |
|
2425
Westamerica Bancorp
WABC
$1.37B
| $1.39M | ﹤0.01% |
24,172
+2,459
| +11% | +$143K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.